FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
Kim Jong Un's Health Problems; Seine Olympic Event Nixed Again; Vegan Diet and Aging Health news and commentary gathered by 鶹ý staff Jul 29, 2024
Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes Also in TTHealthWatch: a monoclonal antibody for ulcerative colitis Jul 27, 2024 podcast
FBI Probes Trump's Injury; RFK Jr. Pushes Farm Therapy; Glucose Monitor Warning Health news and commentary gathered by 鶹ý staff Jul 26, 2024
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues News and commentary from the endocrinology world Jul 23, 2024
People Without Diabetes Make Up Growing Share of GLP-1 Users Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
Sleep Apnea May Accelerate Diabetic Retinopathy Higher rates of progression, interventions, systemic events versus retinopathy without apnea Jul 21, 2024
Nasal Sprays for Respiratory Infections; Paxlovid in COVID Prevention Also in TTHealthWatch: diabetes in kids after COVID Jul 20, 2024 podcast
SGLT-2 Inhibitors Top Other Diabetes Medications for Eye Safety Significantly lower risk of diabetic macular edema, proliferative diabetic retinopathy Jul 20, 2024
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down News and commentary from the endocrinology world Jul 16, 2024
We've Been Here Before: The Politicization of Drug Pricing Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
Pemafibrate Takes a Small Step Forward in Diabetic Foot Ulcers After CVD Flop Signal of reduced ischemic ulceration, gangrene in PROMINENT Jul 15, 2024
New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned News and commentary from the endocrinology world Jul 09, 2024
Tirzepatide Bests Semaglutide for Real-World Weight Loss Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024
Semaglutide May Be Linked to Condition That Causes Blindness Association with optic neuropathy in observational data needs further study to assess causality Jul 03, 2024
CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics News and commentary from the endocrinology world Jul 01, 2024
Many Kids Benefit From GLP-1s. What Happens When They Have to Stop Taking Them? Prepare patients early for a time when medication is no longer an option Jul 01, 2024
Aspirin Overuse; Biotypes of Depression and Anxiety Also in TTHealthWatch: medications and the liver, and managing gestational diabetes Jun 30, 2024 podcast
A Call to Action on Gestational Diabetes Women are failed at every point, and earlier screening and later follow-up are needed, group says Jun 25, 2024
Surprisingly High Hypercortisolism Prevalence With Uncontrolled Type 2 Diabetes Many also had adrenal abnormalities Jun 25, 2024
First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning News and commentary from the endocrinology world Jun 25, 2024
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
Automated Insulin Pump Helps Type 2 Diabetes Control SECURE-T2D trial provides pivotal findings to expand use of the Omnipod 5 System Jun 23, 2024
Donald Sutherland Dies; Can Viagra Benefit Women? Insulin Supply Affected by Wegovy Health news and commentary gathered by 鶹ý staff Jun 21, 2024
Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss News and commentary from the endocrinology world Jun 18, 2024
Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing News and commentary from the endocrinology world Jun 11, 2024
COVID-Flu Vax on the Horizon; Counterfeit Diabetes Devices; Surviving Bird Flu Health news and commentary gathered by 鶹ý staff Jun 11, 2024
FDA Expands Use of RSV Vaccine to Include More Adults Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024
Missing Doc Found Dead; Trump's False Insulin Claim; CDC's Bird Flu Study Health news and commentary gathered by 鶹ý staff Jun 10, 2024
Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks More research from the Endocrine Society's annual meeting Jun 05, 2024
Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024
Semaglutide May Boost Taste Sensitivity Other taste-related changes also potentially seen with the GLP-1 agent in proof-of-concept study Jun 02, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Options "I'm having to jump through hoops to live," says one patient May 26, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD Phase III trial adds a fourth class shown to benefit this population May 24, 2024
Will FDA Advisors Look Past Hypoglycemia Risk With Once-Weekly Insulin? Hypoglycemia was only a concern in patients with type 1 diabetes May 22, 2024
